These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3501321)

  • 1. Differential selectivity of endothelium-derived relaxing factor and nitric oxide in smooth muscle.
    Shikano K; Ohlstein EH; Berkowitz BA
    Br J Pharmacol; 1987 Nov; 92(3):483-5. PubMed ID: 3501321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelium-derived nitric oxide relaxes nonvascular smooth muscle.
    Buga GM; Gold ME; Wood KS; Chaudhuri G; Ignarro LJ
    Eur J Pharmacol; 1989 Feb; 161(1):61-72. PubMed ID: 2542037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of relaxation responses of vascular and non-vascular smooth muscle to endothelium-derived relaxing factor (EDRF), acidified sodium nitrite (NO) and sodium nitroprusside.
    Cocks TM; Angus JA
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Apr; 341(4):364-72. PubMed ID: 2333103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of haemoglobin and erythrocytes on the effects of EDRF, a smooth muscle inhibitory factor, and nitric oxide on vascular and non-vascular smooth muscle.
    Gillespie JS; Sheng H
    Br J Pharmacol; 1988 Dec; 95(4):1151-6. PubMed ID: 3265343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endothelium-derived relaxing factor released from cultured cells: differentiation from nitric oxide.
    Dusting GJ; Read MA; Stewart AG
    Clin Exp Pharmacol Physiol; 1988 Feb; 15(2):83-92. PubMed ID: 3271606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacology of endothelium-derived relaxing factor and nitric oxide.
    Shikano K; Long CJ; Ohlstein EH; Berkowitz BA
    J Pharmacol Exp Ther; 1988 Dec; 247(3):873-81. PubMed ID: 2849673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of the response of venous smooth muscle to arterial endothelium-derived relaxing factor (EDRF) in respect of the role of nitric oxide.
    Vedernikov YP; Gräser T; Tiedt N; Vikhert AM
    Basic Res Cardiol; 1988; 83(2):122-7. PubMed ID: 3260772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inhibition of release of endothelium-derived relaxant factor by manoalide, a potent inhibitor of phospholipase A2.
    Long CJ; Sarau HM; Berkowitz BA
    Br J Pharmacol; 1987 Dec; 92(4):843-9. PubMed ID: 2827828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacology of EDRF and nitric oxide on vascular strips.
    Hutchinson PJ; Palmer RM; Moncada S
    Eur J Pharmacol; 1987 Sep; 141(3):445-51. PubMed ID: 3499329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide?
    Blaise G; To Q; Parent M; Lagarde B; Asenjo F; Sauvé R
    Anesthesiology; 1994 Feb; 80(2):417-26. PubMed ID: 8311324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EDRF generation and release from perfused bovine pulmonary artery and vein.
    Ignarro LJ; Buga GM; Chaudhuri G
    Eur J Pharmacol; 1988 Apr; 149(1-2):79-88. PubMed ID: 3135198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelium-derived vascular relaxing factor.
    Peach MJ; Loeb AL; Singer HA; Saye J
    Hypertension; 1985; 7(3 Pt 2):I94-100. PubMed ID: 2987129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-axial bioassay of a smooth muscle relaxant factor released from guinea-pig tracheal epithelium.
    Fernandes LB; Paterson JW; Goldie RG
    Br J Pharmacol; 1989 Jan; 96(1):117-24. PubMed ID: 2784336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
    Bassenge E; Busse R; Pohl U
    Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor.
    Gryglewski RJ; Palmer RM; Moncada S
    Nature; 1986 Apr 3-9; 320(6061):454-6. PubMed ID: 3007998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular reactivity to endothelium-derived relaxing factor in human umbilical artery at term pregnancy.
    Sugawara M; Tohse N; Nagashima M; Yabu H; Kudo R
    Can J Physiol Pharmacol; 1997 Jul; 75(7):818-24. PubMed ID: 9315349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.